Public SEC Form D records
Biotech Series B Form D filings - August 2026
This page lists the 12 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series B stage in August 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 12
- Issuers
- 12
- Combined disclosed
- $258.8M
Directory links
Filing records
12 crawlable filing links in this facet.
- Halia Therapeutics, Inc.August 31, 2026 / Reg D 506(b) / UT$20.0M
- Eos SENOLYTIX, Inc.August 27, 2026 / Reg D 506(b) / TX$25.0M
- Kayak Therapeutics, Inc.August 21, 2026 / Reg D 506(b) / TX$30.0M
- Outer Biosciences IncAugust 21, 2026 / Reg D 506(b) / MA$23.3M
- Sentonix, Inc.August 20, 2026 / Reg D 506(b) / MA$21.2M
- Harton, Inc.August 14, 2026 / Reg D 506(b) / MA$18.1M
- Nuclein, LLCAugust 14, 2026 / Reg D 506(b) / TX$16.1M
- Biolumic, Inc.August 13, 2026 / Reg D 506(b)$22.1M
- iReprogram, IncAugust 13, 2026 / Reg D 506(b) / MI$25.0M
- Trace Biosciences Inc.August 12, 2026 / Reg D 506(b) / OR$16.2M
- PLEOPHARMA, INC.August 10, 2026 / Reg D 506(b) / PA$15.0M
- Oncologic, Inc. / DEAugust 5, 2026 / Reg D 506(b) / FL$26.7M